Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be unchanged.
B The dose will be increased.
C The dose will be decreased.
D The medication will be stopped.
Question #2
A Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B Not a candidate for fondaparinux based on an insufficient creatinine clearance
C Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
Question #3
A Too high
B Too low
C Within normal limits
D Inadequate to evaluate treatment
Question #4
A Inadequate to evaluate treatment
B Significantly elevated
C Significantly decreased
D Within normal limits
Question #5
A Stop the medication if the systolic blood pressure drops below 110 mm Hg.
B Administer prescribed vitamin K if bruising is observed.
C Monitor liver enzymes.
D Assess for dysrhythmias.
Question #6
A Massaging the site after the injection
B Administering the medication when convenient
C Checking if the patient’s prescription contains enoxaparin
D Administering the medication intramuscularly in the vastus lateralis
Question #7
A “I take ginkgo supplements for memory enhancement.”
B “I eat 1 cup of green leafy vegetables daily.”
C “I refrain from drinking coffee and citrus fruit juices daily.”
D “I do not take aspirin for pain relief.”
Question #8
A “I get up and walk around at least once an hour.”
B “I’ve been on prolonged bed rest.”
C “I never sit with my legs crossed at the knees.”
D “I avoid tight-fitting stockings or leggings.”
Question #9
A Aminocaproic acid
B Phytonadione
C Tranexamic acid
D Alteplase
Question #10
A Carbamazepine
B Cimetidine
C Barbiturate
D Cholestyramine
Question #11
A Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
B Heart rate, Hemoglobin, Blood pressure
C Platelet count, Heart rate, Blood pressure
D Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A “I will store the bottle in a dry place.”
B “I will take the medication with food.”
C “I will place the pills in an organizer for easy use.”
D “I will use the medication within 60 days after it is opened.”
Question #13
A Loss of 10 pounds
B Platelet count of 80,000/mm3
C Creatinine clearance of 25 mL/min
D Diagnosis of diabetes mellitus
Question #14
A The dosage of the amiodarone will be decreased by half.
B The dosage of the warfarin will be decreased by half.
C The dosage of the warfarin will be increased by half.
D The dosage of the amiodarone will be increased by half.
Question #15
A Monitor the patient for decreased action of the anticoagulant.
B Continue to administer cimetidine with each dose of warfarin.
C Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D Monitor the patient for increased action of the anticoagulant.
Question #16
A Gastrointestinal bleed
B Severe chest pain for the past 2 hours
C Local thrombosis from a peripheral intravenous line
D Peptic ulcer disease
Question #17
A Stop the medication.
B Increase the dose of heparin.
C Monitor the patient and check the therapeutic range.
D Notify the health care provider immediately.
Question #18
A Within the expected target therapeutic level of anticoagulation
B Cannot be interpreted without knowing the prothrombin time and international normalized ratio
C Outside the expected target therapeutic level of anticoagulation; it is too low
D Outside the expected target therapeutic level of anticoagulation; it is too high
Question #19
A Prothrombin time: 13 sec
B Hemoglobin level: 11 g/dL
C Platelet count: 100,000/mm3
D Leukocyte count: 3000 cells/mm3
Question #20
A Chronic obstructive pulmonary disease, Atrial fibrillation
B Atrial fibrillation, History of myocardial infarction
C History of myocardial infarction, Chronic obstructive pulmonary disease
D Peptic ulcer disease, Chronic kidney disease
Question #21
A Platelet count of 95,000/mm3
B Potassium level of 3.5 mEq/L
C International normalized ratio (INR) of 1
D Activated partial thromboplastin time (aPTT) of 37 seconds
Question #22
A Within the expected target therapeutic level of anticoagulation
B Outside the expected target therapeutic level of anticoagulation; it is too high
C The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A “Refrigerate and keep away from direct sunlight.”
B “Remove from the original package and place in aluminum foil.”
C “Discard the drug within 21 days of opening the original container.”
D “Store the drug with the desiccant-drying agent in the packing cap.”
Question #24
A Amiodarone
B Ketoconazole
C Furosemide
D Enoxaparin
Question #25
A Teach the patient about dietary restrictions while on the medication.
B Monitor the patient’s laboratory values correctly.
C Ensure that a loading dose was initially administered when beginning
D Have protamine sulfate readily available at all times.
Question #26
A Wait for the INR to decrease.
B Administer vitamin K1 (phytonadione) IV.
C Administer protamine sulfate IV.
D Stop the intravenous (IV) drip.
Question #27
A Reversal of damage from the infarction
B Dissolution of the clot that caused the heart attack
C Prevention of new clots from forming
D A quick decrease in pain
Question #28
A “I should follow a low-cholesterol diet during the therapy.”
B “I should refrain from eating broccoli during the therapy.”
C “I should not use any acetaminophen during the therapy.”
D “I should take oral contraceptives during the therapy.”
Question #29
A “I should keep taking ibuprofen for my arthritis.”
B “I should use a soft toothbrush for dental hygiene.”
C “I should decrease the dose if I start bruising easily.”
D “I will double my dose if I forget to take it the day before.”
Question #30
A “The only difference is that regular heparin dosing is based on the patient’s weight.”
B “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
C “There is no real difference; dalteparin is interchangeable with regular heparin.”
D “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
Question #31
A Rub the administration site after injecting.
B Utilize the Z-track method to inject the medication.
C Administer the medication into subcutaneous tissue of the abdomen.
D Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
Question #32
A “I will avoid contact sports.”
B “I will increase dark green leafy vegetables in my diet.”
C “I will take my medication at the same time each day.”
D “I will contact my health care provider if I develop excessive bruising.”
Question #33
A Protamine sulfate
B Calcium gluconate
C Vitamin E
D Vitamin K
Question #34
A Vitamin K daily
B Aspirin daily (i.e., 81 mg)
C Warfarin daily
D Recombinant factors
Question #35
A Transient ischemic attack
B Acute unstable angina
C Vitamin K deficiency
D Peripheral vascular disease
Question #36
A Heparin subcutaneously
B Dabigatran orally
C Enoxaparin intramuscularly
D Warfarin orally
Question #37
A Urine culture
B Over-the-counter medications
C Platelet level
D Ingestion of acetaminophen
Question #38
A July 31
B September 15
C August 29
D October 1
Question #39
A Edema
B Nausea
C Chest pain
D Itching
Question #40
A Platelet count of 150,000 mm3
B Activated partial thromboplastin time (aPTT) of 120 seconds
C Blood urea nitrogen (BUN) level of 12 mg/dL
D International normalized ratio (INR) of 1.0
Question #41
A Hemoglobin level of 16.5 g/dL
B Creatinine clearance value of 40 mL/min
C Fasting blood glucose level of 95 mg/dL
D Platelet count of 75,000 cell/μL
Question #42
A Antithrombin III
B Vitamin K
C Factor Xa
D Thrombin
Question #43
A Aminocaproic acid
B Alteplase
C Tranexamic acid
D Desmopressin
Question #44
A Antifibrinolytic
B Antiplatelet
C Anticoagulant
D Thrombolytic
Question #45
A Cardiomyopathy
B Heart failure
C Coronary artery disease
D Acute myocardial infarction
Question #46
A Pentoxifylline
B Dipyridamole
C Aspirin
D Cilostazol
Question #47
A Enoxaparin
B Dabigatran
C Fondaparinux
D Argatroban
Question #48
A Selective factor Xa inhibitors
B Heparins
C Direct thrombin inhibitors
D Warfarin
Question #49
A Anticoagulants alter platelet function.
B Anticoagulants prevent clots from forming.
C Anticoagulants dissolve clots.
D Anticoagulants interfere with drug metabolism.
Question #50
A Anticoagulant
B Antifibrinolytic
C Antiplatelet
D Thrombolytic
Question #51
A Medication reaction
B Anxiety
C Fatigue from walking with pain
D Embolus to the lungs
Question #52
A Infusing 50 mL of warfarin sodium
B Administering protamine sulfate
C Increasing the dose of enoxaparin
D Administering vitamin K1
Question #53
A Potassium
B Calcium
C Vitamin K
D Aspirin